• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children.

作者信息

Xanthakos Stavra A, Ibrahim Samar H, Adams Kathryn, Kohli Rohit, Sathya Pushpa, Sundaram Shikha, Vos Miriam B, Dhawan Ashish, Caprio Sonia, Behling Cynthia A, Schwimmer Jeffrey B

机构信息

Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Hepatology. 2025 Apr 29. doi: 10.1097/HEP.0000000000001368.

DOI:10.1097/HEP.0000000000001368
PMID:
40300071
Abstract
摘要

相似文献

1
AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children.美国肝病研究学会关于儿童代谢功能障碍相关脂肪性肝病评估与管理的实践声明。
Hepatology. 2025 Apr 29. doi: 10.1097/HEP.0000000000001368.
2
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.代谢相关脂肪性肝病：新命名对美国肝病研究学会非酒精性脂肪性肝病实践指南的影响及更新。
Hepatology. 2024 May 1;79(5):1212-1219. doi: 10.1097/HEP.0000000000000670. Epub 2023 Nov 9.
3
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD.代谢相关脂肪性肝病时代非侵入性评分和血清生物标志物在脂肪性肝病中的应用：从非酒精性脂肪性肝病到代谢相关脂肪性肝病和脂肪性肝病的综合评价。
Curr Obes Rep. 2024 Sep;13(3):510-531. doi: 10.1007/s13679-024-00574-z. Epub 2024 May 29.
4
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。执行摘要。
Diabetologia. 2024 Nov;67(11):2375-2392. doi: 10.1007/s00125-024-06196-3.
5
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.用于检测代谢功能障碍相关脂肪性肝病患者显著纤维化的非侵入性检测组合并不优于单独使用磁共振弹性成像。
Eur Radiol. 2024 Jun;34(6):3882-3888. doi: 10.1007/s00330-023-10441-5. Epub 2023 Nov 21.
6
Gaps and challenges in the management of pediatric steatotic liver diseases: a narrative review.小儿脂肪性肝病管理中的差距与挑战：一篇叙述性综述
World J Pediatr. 2025 Apr;21(4):352-360. doi: 10.1007/s12519-025-00902-w. Epub 2025 Apr 19.
7
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。
Obes Facts. 2024;17(4):374-444. doi: 10.1159/000539371. Epub 2024 Jun 7.
8
Noninvasive identification of metabolic dysfunction-associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study.代谢功能障碍相关脂肪性肝炎的非侵入性识别（INFORM MASH）：一项回顾性队列和疾病建模研究。
Expert Rev Gastroenterol Hepatol. 2025 Apr;19(4):427-435. doi: 10.1080/17474124.2025.2477249. Epub 2025 Mar 21.
9
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7.
10
Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice.非酒精性脂肪性肝病（NAFLD）的筛查、诊断和分期：学会指南在临床实践中的应用。
Curr Gastroenterol Rep. 2023 Oct;25(10):213-224. doi: 10.1007/s11894-023-00883-8. Epub 2023 Sep 28.

引用本文的文献

1
Weight gain in infancy and metabolic dysfunction-associated steatotic liver disease (MASLD) in a prospective birth cohort of Latino children.拉丁裔儿童前瞻性出生队列中的婴儿期体重增加与代谢功能障碍相关脂肪性肝病（MASLD）
Matern Health Neonatol Perinatol. 2025 Aug 15;11(1):25. doi: 10.1186/s40748-025-00225-8.
2
Lifestyle Intervention Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Down Syndrome.生活方式干预改善唐氏综合征患儿代谢功能障碍相关脂肪性肝病
Nutrients. 2025 Jul 16;17(14):2331. doi: 10.3390/nu17142331.